HALOZYME THERAPEUTICS, INC.: revenue
| Value | {"amount": 151862000, "concept": "us-gaap:Revenues", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-09-01T13:26:33.445923+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ba4ddbc2-7d7b-4df9-b9a7-ca66b5169d0d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-19-000006Retrieved: 2026-09-01T13:26:33.445923+02:00
Raw response sha256:
09ca2466c06425bbd1ba706e3a09155b…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/revenue/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ba4ddbc2-7d7b-4df9-b9a7-ca66b5169d0d
History
- supersedes {"amount": 151862000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001159036-20-000013)